Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesStudy to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis
Mycoses, 06/30/09
Yim SM et al. - According to this study, on comparing the efficacy of cure of superficial dermatomycosis after 4 weeks of application, both fluconazole 0.5% and fluconazole 1% cream were found to be equally effective and non-inferior to flutrimazole 1% cream. Given the effectiveness and safety of the drug, both fluconazole 0.5% and 1% cream might be said to be optimal concentration in the treatment of superficial dermatomycosis.
Related Articles
Algorithm of Clinical Protocol Lowering the Risk of Systemic Mycosis Infections in Allografts Recipients
Transplantation Proceedings, 11/11/09
Relevance Score: 85%
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sezary syndrome
Journal of Cutaneous Pathology, 11/06/09
Relevance Score: 84%
Cerebral mycosis: 7-year retrospective series in a tertiary center
Neuropathology, 11/03/09
Relevance Score: 84%
Paracoccidioidomycosis
Paediatric Respiratory Reviews, 11/10/09
Relevance Score: 82%
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology, 10/20/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
vancomycinpharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections
Expert Review of Anti-infective Therapy, 12/17/09
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
Expert Review of Anti-infective Therapy, 12/17/09
Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins
Expert Review of Anti-infective Therapy, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor